Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 30;16(9):e70568.
doi: 10.7759/cureus.70568. eCollection 2024 Sep.

Dietary Interventions in Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes, Microbiota Changes, and Inflammatory Markers

Affiliations
Review

Dietary Interventions in Irritable Bowel Syndrome: A Systematic Review of Clinical Outcomes, Microbiota Changes, and Inflammatory Markers

Muhammad Shams et al. Cureus. .

Abstract

This systematic review synthesizes findings from 12 studies to evaluate the effectiveness of dietary interventions in managing irritable bowel syndrome (IBS), with a focus on low-FODMAP (fermentable oligosaccharides, disaccharides, monosaccharides, and polyols) diets, probiotics, and prebiotics. The review rigorously follows the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines and includes studies selected through comprehensive database searches. In adults diagnosed with IBS, this review assesses how effective dietary interventions, specifically low-FODMAP diets, probiotics, and prebiotics, are compared to standard management or placebo in improving clinical outcomes, modifying gut microbiota composition, and reducing inflammatory markers. Our analysis reveals that low-FODMAP diets consistently alleviate IBS symptoms and improve quality of life. However, the effectiveness of probiotics and prebiotics varies, with outcomes dependent on specific strains and individual patient microbiota profiles. The studies demonstrate significant improvements in gastrointestinal symptoms and microbiota composition, highlighting the potential of dietary strategies to beneficially modify gut health. However, the research points to the necessity of personalizing dietary approaches based on individual responses and microbiota profiles to optimize treatment efficacy. The risk of bias was assessed using the Cochrane risk-of-bias 2 tool for randomized controlled trials (RCTs) and the AMSTAR 2 tool for systematic reviews, with varying degrees of bias across the studies. This review identifies gaps in the long-term efficacy of these interventions and calls for more extensive trials to explore their sustained impacts. Our findings suggest that dietary management should be integrated into routine IBS treatment protocols and emphasize the need for further research to establish standardized dietary recommendations tailored to patient-specific characteristics.

Keywords: dietary interventions; gastrointestinal disorders; gut health; irritable bowel syndrome; nutrition therapy.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. The PRISMA flowchart representing the study selection process.
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses

References

    1. Irritable bowel syndrome. Weaver KR, Melkus GD, Henderson WA. Am J Nurs. 2017;117:48–55. - PMC - PubMed
    1. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. Saha L. World J Gastroenterol. 2014;20:6759–6773. - PMC - PubMed
    1. The neurobiology of irritable bowel syndrome. Mayer EA, Ryu HJ, Bhatt RR. Mol Psychiatry. 2023;28:1451–1465. - PMC - PubMed
    1. The microbiome and irritable bowel syndrome - a review on the pathophysiology, current research and future therapy. Chong PP, Chin VK, Looi CY, Wong WF, Madhavan P, Yong VC. Front Microbiol. 2019;10:1136. - PMC - PubMed
    1. Dietary modulation of gut microbiota for the relief of irritable bowel syndrome. Kim MY, Choi SW. Nutr Res Pract. 2021;15:411–430. - PMC - PubMed